risk management
Balancing regulatory approval with biotech innovation
September 15 by Pharma IQThis Pharma IQ report explores how key players in pharma and biotech are balancing regulation of new drug products while ensuring the industry is able to become more innovative
Keeping tabs on Covid-19: Cell and gene clinical trials advance despite Covid-19 crisis and new clinical trial studies partner with big pharma
August 07 by Emily UwemedimoClinical study teams are working with regulatory bodies and big pharma partners to keep clinical trials on track in the evolving Covid-19 environment